The Technical Table on Rare Diseases was established on 21 June 2021. The Table brings together clinical and academic experts, institutional representatives and
The Incisive Health Morning Club co-organised by Nomos Centro Studi Parlamentari and Pharma Value in cooperation with The Health Link was held on 20 May,
AIFA has published a communication on the update of national requirements to be included in the Blue Box. There is a major impact on the regulatory activities of companies in
OsMed's 1st Report on Parallel Import (IP) and Export of Medicines for Human Use by AIFA You can review it here https://lnkd.in/dRgRGUV AIFA's presentation explains
AIFA has published a new application form for the listing of medicines under Law 648/96; there are some new features compared to
On 14 December 2020, AIFA established a scientific committee for the post-marketing surveillance of COVID-19 vaccines (CSV-Covid19). The CSV-Covid19 will remain in office for two
With the Decree of the Head of the Civil Protection Department No. 371 of 5 February 2020, the Technical Scientific Committee (STC) was established. It has a
Pharma Value's notes return with an update on the composition of the Working Group for the Coordination of the National Strategy to Combat Antimicrobial Resistance. This WG
On 30 December 2020 AIFA approved the document containing the provisions required by art. 2 of Ministerial Decree of 2 August 2019, 'Criteria and procedures
On 29 December, the 2019 National Report 'The use of antibiotics in Italy' was presented, which provides data and analysis on consumption trends and
